BIM
ENZ

Bogle Investment Management’s Enzo Biochem, Inc. ENZ Stock Holding History

Bogle Investment Management’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-15,674
Closed -$127K – 389
2017
Q4 		$127K Sell
15,674
-99,116
-86% -$947K 0.01% 272
2017
Q3 		$1.2M Buy
114,790
+7,214
+7% +$80.1K 0.08% 212
2017
Q2 		$1.19M Buy
+107,576
New +$1M 0.09% 186
2015
Q2 		– Sell
-116,370
Closed -$343K – 440
2015
Q1 		$343K Sell
116,370
-15,276
-12% -$50K 0.02% 309
2014
Q4 		$584K Sell
131,646
-8,767
-6% -$41.8K 0.04% 291
2014
Q3 		$723K Sell
140,413
-45,590
-25% -$243K 0.05% 270
2014
Q2 		$976K Buy
+186,003
New +$804K 0.07% 238

Other funds holding ENZ

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bogle Investment Management's ENZ Position: Q1 2018 in Review

Bogle Investment Management sold out of Enzo Biochem, Inc. (ENZ) in Q1 2018, closing a stake of 15,674 shares — an estimated $127K sold.

Bogle Investment Management first reported a position in ENZ in Q2 2014 and held it in 7 quarters. The position peaked at $1.2M in Q3 2017. 107 funds tracked by Wall St. Rank hold ENZ as of Q1 2018.

  • Bogle Investment Management reported no remaining Enzo Biochem, Inc. position as of Q1 2018 after selling out during the quarter.
  • Bogle Investment Management sold 15,674 Enzo Biochem, Inc. shares in Q1 2018, an estimated $127K.
  • Bogle Investment Management first reported a position in Enzo Biochem, Inc. in Q2 2014 and held it in 7 quarters.
  • Bogle Investment Management's Enzo Biochem, Inc. position peaked at $1.2M in Q3 2017.
  • 107 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q1 2018.

Based on Bogle Investment Management's 13F filing for Q1 2018, filed 14 May 2018.